journal article·2014-04

An evidence on G2/M arrest, DNA damage and caspase mediated apoptotic effect of biosynthesized gold nanoparticles on human cervical carcinoma cells (HeLa)

M. Jeyaraj, R. Arun, G. Sathishkumar, D. MubarakAli, M. Rajesh, G. Sivanandhan, G. Kapildev, M. Manickavasagam, N. Thajuddin, A. Ganapathi

Publisher page

Abstract

Abstract Current prospect of nanobiotechnology involves in the greener synthesis of nanostructured materials particularly noble metal nanoparticles for various biomedical applications. In this study, biologically (Podophyllum hexandrum L.) synthesized crystalline gold nanoparticles (AuNPs) with the size range between 5 and 35 nm were screened for its anticancereous potential against human cervical carcinoma cells (HeLa). Stoichiometric proportion of the reaction mixture and conditions were optimized to attain stable nanoparticles with narrow size range. Different high throughput techniques like transmission electron microscope (TEM), X-ray diffraction (XRD) and UV–vis spectroscopy were adopted for the physio-chemical characterization of AuNPs. Additionally, Fourier transform infrared spectroscopy (FTIR) study revealed that the water soluble fractions present in the plant extract solely influences the reduction of AuNPs. Sublimely, synthesized AuNPs exhibits an effective in vitro anticancer activity against HeLa cells via induction of cell cycle arrest and DNA damage. Furthermore, it was evidenced that AuNPs treated cells are undergone apoptosis through the activation of caspase cascade which subsequently leads to mitochondrial dysfunction. Thereby, this study proves that biogenic colloidal AuNPs can be developed as a promising drug candidature for human cervical cancer therapy.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Laser-Ablation Synthesis of Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Soenen · Nano Today · 2011 · 6 · 44610.1016/j.nantod.2011.08.001 ↗
2. Ahmed · Drug Discov. Today · 2012 · 17 · 92810.1016/j.drudis.2012.03.010 ↗
3. Cui · Nanomed. Nanotechnol. Biol. Med. · 2013 · 9 · 26410.1016/j.nano.2012.05.016 ↗
4. MubarakAli · Colloid Surf. B: Biointerfaces · 2011 · 85 · 36010.1016/j.colsurfb.2011.03.009 ↗
5. MubarakAli · Colloids Surf. B: Biointerfaces · 2013 · 103 · 16610.1016/j.colsurfb.2012.10.014 ↗
6. Sathishkumar · Colloids Surf. B: Biointerfaces · 2012 · 95 · 23510.1016/j.colsurfb.2012.03.001 ↗
7. Dubey · Process Biochem. · 2010 · 45 · 106510.1016/j.procbio.2010.03.024 ↗
8. Priyadarshini · Colloids Surf. B: Biointerfaces · 2013 · 102 · 23210.1016/j.colsurfb.2012.08.018 ↗
9. Rao · Mater. Res. Bull. · 2013 · 48 · 116610.1016/j.materresbull.2012.12.025 ↗
10. Kanipandian · Mater. Res. Bull. · 2014 · 49 · 49410.1016/j.materresbull.2013.09.016 ↗
11. Misra · Drug Discov. Today · 2010 · 15 · 84210.1016/j.drudis.2010.08.006 ↗
12. Gopinath · Colloids Surf. B: Biointerfaces · 2012 · 96 · 6910.1016/j.colsurfb.2012.03.023 ↗
13. Cho · Clin. Cancer Res. · 2008 · 14 · 131010.1158/1078-0432.CCR-07-1441 ↗
14. Chaurasia · Indian J. Traditional Knowledge · 2012 · 11 · 234
15. Ganie · Asian Pac. J. Trop. Biomed. · 2012 · 160010.1016/S2221-1691(12)60460-2 ↗
16. Moshmann · Immunol. J. Methods · 1983 · 65 · 5510.1016/0022-1759(83)90303-4 ↗
17. Hafer · Radiat. Res. · 2008 · 169 · 46010.1667/RR1212.1 ↗
18. Darzynkiewicz · Methods Cell Biol. · 1994 · 41 · 1510.1016/S0091-679X(08)61707-0 ↗
19. Singh · Exp. Cell Res. · 1988 · 175 · 18410.1016/0014-4827(88)90265-0 ↗
20. Allen · J. Pharmacol. Toxicol. Methods · 1997 · 37 · 21510.1016/S1056-8719(97)00033-6 ↗
21. Zhou · Int. J. Biochem. Cell Biol. · 2002 · 34 · 67810.1016/S1357-2725(01)00176-5 ↗
22. Paciotti · Drug Dev. Res. · 2006 · 67 · 4710.1002/ddr.20066 ↗
23. Kumar · Biomaterials · 2012 · 33 · 118010.1016/j.biomaterials.2011.10.058 ↗
24. Murphy · Acc. Chem. Res. · 2008 · 41 · 172110.1021/ar800035u ↗
25. Philip · Spectrochim. Acta Part A. · 2009 · 73 · 37410.1016/j.saa.2009.02.037 ↗
26. Sadowski · Mater. Sci. · 2008 · 26 · 419
27. Zhou · Nanoscale Res. Lett. · 2010 · 5 · 135110.1007/s11671-010-9652-8 ↗
28. Gan · Bioresour. Technol. · 2012 · 113 · 13210.1016/j.biortech.2012.01.015 ↗
29. Guidelli · Spectrochim. Acta Part A · 2011 · 82 · 14010.1016/j.saa.2011.07.024 ↗
30. Jeyaraj · Colloids Surf. B: Biointerfaces · 2013 · 106 · 8610.1016/j.colsurfb.2013.01.027 ↗
31. Jeyaraj · Colloids Surf. B: Biointerfaces · 2013 · 102 · 70810.1016/j.colsurfb.2012.09.042 ↗
32. Geetha · Cancer Nano · 2013 · 4 · 9110.1007/s12645-013-0040-9 ↗
33. Nel · Science · 2006 · 311 · 62210.1126/science.1114397 ↗
34. Tedesco · Aquat. Toxicol. · 2010 · 100 · 17810.1016/j.aquatox.2010.03.001 ↗
35. Pan · Small · 2007 · 3 · 194110.1002/smll.200700378 ↗
36. Green · Science · 1998 · 281 · 130910.1126/science.281.5381.1309 ↗
37. Kroemer · Immunol. Today · 1997 · 8 · 4410.1016/S0167-5699(97)80014-X ↗
38. Selim · Asian Pac. J. Cancer Prev. · 2012 · 13 · 161710.7314/APJCP.2012.13.4.1617 ↗
39. Matesanz · Biomaterials · 2013 · 34 · 156210.1016/j.biomaterials.2012.11.001 ↗
40. Chuang · Biochim. Biophys. Acta · 2013 · 1830 · 496010.1016/j.bbagen.2013.06.025 ↗